Update On Life-Saving Diabetes Drug Jardiance

A new paper in the New England Journal of Medicine, reported that patients who took Jardiance, a novel hypoglycemic drug that was developed by Boehringer and Lilly, had a 38 percent reduction in cardiovascular deaths. This is the first evidence that a drug that lowers blood sugar has an impact on cardiovascular disease. Continue reading →